Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Illumina, Inc.    ILMN   US4523271090

ILLUMINA, INC. (ILMN)

56
Delayed Quote. Delayed Nasdaq - 10/31 04:00:01 pm
192.58 USD   -0.43%
1d ago ILLUMINA : HTG Announces Completion of IVD Development and Supply Agreement..
10/21 Wall St. extends rebound on earnings, ECB report
10/21 NASDAQ 100 MOVERS : Spls, ilmn
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
191.31(c) 190.65(c) 188.88(c) 193.42(c) 192.58 Last
1 343 683 1 040 584 831 457 1 277 342 1 248 128 Volume
+1.16% -0.34% -0.93% +2.40% -0.43% Change
More quotes
Company
Illumina, Inc. develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function.The company provides sequencing and array-based solutions for genotyping, copy-number variation analysis, methylation studies and gene expression profiling... 
Surperformance© rating of Illumina, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1 855 M
EBIT 2014 532 M
Net income 2014 296 M
Debt 2014 633 M
Yield 2014 -
Sales 2015 2 268 M
EBIT 2015 662 M
Net income 2015 390 M
Finance 2015 475 M
Yield 2015 -
PER 2014 96,77
PER 2015 72,53
EV / Sales 2014 15,1x
EV / Sales 2015 11,9x
Capitalization 27 466 M
More Financials
Latest news on ILLUMINA, INC.
8h ago ILLUMINA : Sources Sought Notice - A-- Genomics & Microarray Services - Eastern ..
1d ago ILLUMINA : HTG Announces Completion of IVD Development and Supply Agreement With..
2d ago ILLUMINA : Management's Discussion and Analysis of Financial Condition and Resul..
2d ago Macrogen Introduces Latest Service Portfolio and Presents Research Outcome at..
2d ago ILLUMINA : Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems
2d ago BOSTON SCIENTIFIC : Receives FDA And CE Mark Approval For New CoverEdge™ S..
2d ago ILLUMINA : PEDANT Application for Convenient, Comprehensive Genomic Analysis Now..
2d ago ILLUMINA : Special Notice - SEQUENCING REAGENTS AND CONSUMABLES FOR ILLUMINA NEX..
4d ago ILLUMINA : Assigned Patent
10/21 Wall St. extends rebound on earnings, ECB report
10/21 NASDAQ 100 MOVERS : Spls, ilmn
10/20 ILLUMINA : beats Street 3Q forecasts
More news
4-Traders Strategies on ILLUMINA, INC. 
2013End of the technical recovery
More Strategies


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF